Trends in hospitalization characteristics for pediatric nephrotic syndrome in the USA

Clinical Nephrology

Volumn 78, Issue 2, 2012, Pages 106-111

  Ayoob, Rose M ^a   Hains, David S ^a   Smoyer, William E ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Costs; Economics; Epidemiology; Survival

Indexed keywords

ADOLESCENT; ARTICLE; CHILD; FEMALE; HEALTH CARE COST; HOSPITAL CHARGE; HOSPITALIZATION; HUMAN; ICD-9-CM; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROTIC SYNDROME; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; UNITED STATES;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INFANT; MALE; NEPHROTIC SYNDROME; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84865081955     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107303     Document Type: Article

References (28)

1. Rudolph P. Valentini WES. Nephrotic Syndrome. In: Kanwal K Kher MHWS, MD; Sudesh Paul Makker, MD, FASN (ed). Clinical Pediatric Nephrology. 2nd ed. London: Informa Healthcare; 2006. p. 155-194.
2. Report of the International Study of Kidney Disease in Children. Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years' observation. Pediatrics. 1984; 73: 497-501. PubMed.
3. Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Trachtman H, Greenbaum LA. Management of childhood onset nephrotic syndrome. Pediatrics. 2009; 124: 747-757. doi:10.1542/pe ds.2008-1559 PubMed.
4. Tanaka R, Yoshikawa N, Kitano Y, Ito H, Nakamura H. Long-term ciclosporin treatment in children with steroid-dependent nephrotic syndrome. Pediatr Nephrol. 1993; 7: 249-252. doi:10.1007/BF00853209 PubMed.
5. Rüth EM, Kemper MJ, Leumann EP, Laube GF, Neuhaus TJ. Children with steroid-sensitive nephrotic syndrome come of age: long-term outcome. J Pediatr. 2005; 147: 202-207. doi:10.1 01 6/j.jpeds.2005.03.050 PubMed.
6. Lechner BL, Bockenhauer D, Iragorri S, Kennedy TL, Siegel NJ. The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome. Pediatr Nephrol. 2004; 19: 744-748. doi:10. 1007/s00467-004-1460-x PubMed.
7. Hegarty J, Mughal MZ, Adams J, Webb NJ. Reduced bone mineral density in adults treated with high-dose corticosteroids for childhood nephrotic syndrome. Kidney Int. 2005; 68: 2304-2309. doi: 10.1111/j.1523-1755.2005.00690.x PubMed.
8. Foster BJ, Shults J, Zemel BS, Leonard MB. Risk factors for glucocorticoid-induced obesity in children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2006; 21: 973-980. doi:10.1007/s00467-006-0100-z PubMed.
9. Emma F, Sesto A, Rizzoni G. Long-term linear growth of children with severe steroid-responsive nephrotic syndrome. Pediatr Nephrol. 2003; 18: 783-788. doi:10.1007/s00467-003-1176-3 PubMed.
10. Elzouki AY, Jaiswal OP. Long-term, small dose prednisone therapy in frequently relapsing nephrotic syndrome of childhood. Effect on remission, statural growth, obesity, and infection rate. Clin Pediatr (Phila). 1988; 27: 387-392. doi:10.1177/000992288802700807 PubMed.
11. Donatti TL, Koch VH, Fujimura MD, Okay Y. Growth in steroid-responsive nephrotic syndrome: a study of 85 pediatric patients. Pediatr Nephrol. 2003; 18: 789-795. doi:10.1007/s00467-003-1142-0 PubMed.
12. Berns JS, Gaudio KM, Krassner LS, Anderson FP, Durante D, McDonald BM, Siegel NJ. Steroid-responsive nephrotic syndrome of childhood: a longterm study of clinical course, histopathology, efficacy of cyclophosphamide therapy, and effects on growth. Am J Kidney Dis. 1987; 9: 108-114. PubMed.
13. Olbricht CJ, Wanner C, Thiery J, Basten A; Simvastatin in Nephrotic Syndrome Study Group. Simvastatin in nephrotic syndrome. Kidney Int Suppl. 1999; 71 (S71): S113-S116. doi:10.10 46/j.1523-1755.1999.07128.x PubMed.
14. Merritt RJHS, Hack SL, Kalsch M, Olson D. Corticosteroid therapy-induced obesity in children. Clin Pediatr (Phila). 1986; 25: 149-152. doi:10.1177/000992288602500304 PubMed.
15. United States Department of Labor. Bureau of Labor Statistics.http://www.bls.gov/data/inflation_calculator.htm.
16. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 2004; 57: 131-141. doi:10.1016/S0895-4356(03)00246-4PubMed.
17. Hsia DC, Krushat WM, Fagan AB, Tebbutt JA, Kusserow RP. Accuracy of diagnostic coding for Medicare patients under the prospective-payment system. N Engl J Med. 1988; 318: 352-355. doi:10.1056/NEJM198802113180604 PubMed.
18. Fisher ES, Whaley FS, Krushat WM, Malenka DJ, Fleming C, Baron JA, Hsia DC. The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. Am J Public Health. 1992; 82: 243-248. doi:10.2105/AJPH.82.2.243 PubMed.
19. Albertsen PCKE, Kamens EA. Variations in coding practices among Connecticut urologists for the Medicare population. Conn Med. 1990; 54: 508-511. PubMed.
20. HCaUP. HCUP Kid's Inpatient Database (KID). Healthcare Cost and Utilization Project (HCUP). Rockville, MD; 2000, 2003, and 2006.
21. Houchens REA. Final Report on Calculating National Inpatient Sample (NIS) Variances: U.S. Agency for Healthcare Research and Quality; 2001.
22. American Fact Finder. U.S. Census Bureau: Census US. 2000 Summary File 1.: U.S. Census Bureau; 2000.
23. Owens PLTJ, Elixhauser A, Ryan K. Factbook. Rockville, MD: Agency for Healthcare Research and Quality; 2003.
24. Nash MAEC. Bernstein J et al. The nephrotic syndrome. In: CMJ E (ed). Pediatric Kidney Disease. Boston: Little, Brown, and Company; 1992. p. 1247.
25. Clark AGBT. Steroid-responsive nephrotic syndrome. In: Barratt TMAE, Harmon WE. (ed). Pediatric Nephrology. Baltimore: Lippincott, Williams & Wilkins.; 1998. p. 731.
26. NACHRI. All Children Need Children's Hospitals. Alexandria, VA: NACHRI; 2002.
27. Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending. Part 2: Health outcomes and satisfaction with care. Ann Intern Med. 2003; 138: 288-298.
28. Kenney M, Ruther J, Selden TM. Containing costs and improving care for children in medicaid and CHIP. Health Affairs. 2009; 28: w1025-w1036.